Verrica Pharmaceuticals Inc.
NASDAQ:VRCA
5.105 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7.566 | 5.124 | 9.032 | 12 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.853 | 0.746 | 0.725 | 0.472 | 0.229 | 0.257 | 0.02 | 0 | 0 |
| Gross Profit
| 5.713 | 4.378 | 8.307 | 11.528 | -0.229 | -0.257 | -0.02 | 0 | 0 |
| Gross Profit Ratio
| 0.755 | 0.854 | 0.92 | 0.961 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 11.84 | 20.295 | 12.198 | 15.929 | 15.673 | 15.436 | 12.826 | 3.73 | 1.709 |
| General & Administrative Expenses
| 58.018 | 47.302 | 17.405 | 26.979 | 24.508 | 14.644 | 9.052 | 0.727 | 0.204 |
| Selling & Marketing Expenses
| 0.004 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 58.822 | 47.305 | 17.405 | 26.979 | 24.508 | 14.644 | 9.052 | 0.727 | 0.204 |
| Other Expenses
| 0.97 | 2.537 | 0 | -0.472 | -0.229 | 0 | -0.001 | 0 | 0 |
| Operating Expenses
| 71.632 | 70.137 | 29.603 | 42.436 | 39.952 | 30.08 | 21.878 | 4.457 | 1.913 |
| Operating Income
| -65.919 | -65.759 | -21.296 | -30.908 | -40.181 | -30.08 | -21.878 | -4.457 | -1.913 |
| Operating Income Ratio
| -8.713 | -12.834 | -2.358 | -2.576 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -10.66 | -1.236 | -3.191 | -4.172 | -2.513 | 1.873 | 1.23 | -0.002 | 0 |
| Income Before Tax
| -76.579 | -66.995 | -24.487 | -35.08 | -42.694 | -28.207 | -20.648 | -4.459 | -1.913 |
| Income Before Tax Ratio
| -10.121 | -13.075 | -2.711 | -2.923 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | -0.257 | 0 | 0 | 0 |
| Net Income
| -76.579 | -66.995 | -24.487 | -35.08 | -45.497 | -27.95 | -20.648 | -4.459 | -1.913 |
| Net Income Ratio
| -10.121 | -13.075 | -2.711 | -2.923 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -14.78 | -14.78 | -7.17 | -12.97 | -17.08 | -11.33 | -14.082 | -3.798 | -0.745 |
| EPS Diluted
| -14.78 | -14.78 | -7.17 | -12.97 | -17.08 | -11.33 | -14.082 | -3.798 | -0.745 |
| EBITDA
| -65.898 | -62.197 | -21.597 | -30.313 | -39.432 | -30.08 | -20.628 | -4.457 | -1.913 |
| EBITDA Ratio
| -8.71 | -12.138 | -2.391 | -2.526 | 0 | 0 | 0 | 0 | 0 |